Kirkeparken Spesialistpraksis
About Kirkeparken Spesialistpraksis
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
4
Clinical Trials at Kirkeparken Spesialistpraksis
During the past decade, Kirkeparken Spesialistpraksis conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
2017-06-30
2024-06-30
Active, not recruiting
1,272
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
2017-07-31
2021-10-25
Completed
766
Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb
2021-01-29
2022-05-03
Completed
194
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)
2021-10-29
2023-10-05
Active, not recruiting
400
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kirkeparken Spesialistpraksis
According to Clinical.Site data, the most researched conditions in "Kirkeparken Spesialistpraksis" are
"Endometriosis" (1 trials), "Hot Flashes" (1 trials), "Leiomyoma" (1 trials), "Uterine Fibroids" (1 trials) and "Vasomotor Symptoms Associated With Menopause" (1 trials). Many other conditions were trialed in "Kirkeparken Spesialistpraksis" in a lesser frequency.
Clinical Trials Intervention Types at Kirkeparken Spesialistpraksis
Most popular intervention types in "Kirkeparken Spesialistpraksis" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Vilaprisan (BAY1002670)" (2 trials), "BAY1817080" (1 trials), "Elagolix" (1 trials) and "Elinzanetant (BAY3427080)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kirkeparken Spesialistpraksis
The vast majority of trials in "Kirkeparken Spesialistpraksis" are
4 trials for "Female" genders.
Clinical Trials Status at Kirkeparken Spesialistpraksis
Currently, there are NaN active trials in "Kirkeparken Spesialistpraksis".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kirkeparken Spesialistpraksis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kirkeparken Spesialistpraksis, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".